Dr. Ronan Mac Loughlin is currently Head of Respiratory Sciences in Aerogen, an Irish medical device company specialising in Respiratory Drug Delivery. He has more than 16 years’ experience in the design and development of aerosol drug delivery systems and drug device combinations. He currently has more than 70 articles, conference presentations, and conference papers, combined with several patent applications currently under review.
He holds the position of Adjunct Associate Professor in Trinity College Dublin’s (Ireland) Department of Pharmaceutics and Pharmaceutical Technology, Honorary Senior Lecturer in the Royal College of Surgeons Ireland (RCSI), Chairman of the Enterprise Ireland Funded Medical Engineering Technology (MET) Gateway, and Chairman of the Industry Advisory Group for CURAM, the Science Foundation Ireland-funded (€41.3m) medical device research centre. Additionally, he is currently co-chair of the Paediatric and CF working group within the International Society for Aerosols in Medicine (ISAM).
He previously sat on the Gates Foundation Scientific Advisory Board for its inhaled measles vaccine program and was one of the lead developers of the nebuliser selected by the World Health Organisation for their inhaled measles vaccine trials. He also contributed to the latest revision of the international standard ISO27427 (Anaesthetic and respiratory equipment -- Nebulizing systems and components) as a member of the expert reviewer panel.
Ronan is currently involved in several device and drug/device combination development programs that include applications such as aerosol drug delivery to premature infants, inhaled insulin and inhaled vaccines and has successfully sourced more than €5million in external funding for collaborative (academic and commercial) projects over the last 3 years.
